Biogen Idec (BIIB) and Genentech (DNA) Send Letter to Physicians Saying Patients Taking Rituxan Have Died
Tweet Send to a Friend
Biogen Idec (Nasdaq: BIIB) and Genentech, Inc. (NYSE: DNA) are issuing a dear healthcare provider letter to physicians ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
